← Back to ACS BrightEdge Profile
Founders should prepare a solid business plan, clear value proposition, and demonstrate alignment with ACS BrightEdge's investment thesis.
ACS BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society.
Focusing on early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies.
Primarily early-stage investments.
HealthTech, Biotech, Oncology, Pharmacology, Philanthropy, Fundraising.
Cancer-focused therapeutics, diagnostics, devices, and technologies.
ACS BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society, focusing on early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and technologies.
ACS BrightEdge is located in Kennesaw, United States.
This information is not publicly available.
ACS BrightEdge is a Corporate VC and VC Firm.
Yes, ACS BrightEdge invests in HealthTech.
Yes, ACS BrightEdge invests in Biotech.
Verification Confidence: 90% | Source: accepts_cold_outreach | Entity: ACS BrightEdge